NewsRamp Health & Wellness Podcast

Soligenix focuses on patient-centric reformulation strategies, while other biotechs emphasize capital discipline, diversified pipelines, and novel treatments for conditions like global measles and CNS tumors.

BioXgen invites investors to a live webinar on April 30, 2026, showcasing its breakthrough cardiac patch to address postoperative atrial fibrillation in open-heart surgery patients.

Cardio Diagnostics Holdings integrates epigenetics, genetics, and AI; Soligenix receives orphan drug designation for Behçet’s disease; Oragenics progresses in Phase IIa concussion therapy trial; Aditxt's precision oncology subsidiary showcases predictive assays; and Ocumetics reports improved vision results.

Biotech companies like Oncotelic Therapeutics Inc. demonstrate how scientific progress in drug pipelines is now seen as a financial asset, shaping financial strategies in the industry.

Lixte Biotechnology leads with LB-100 in combination therapies for solid tumors. HeartBeam's $10M funding boosts cardiac tech. Soligenix makes strides in CTCL research.

Soligenix Inc. is utilizing synthetic hypericin for dermatologic treatments, while a new breakthrough in Glioblastoma treatment offers hope for patients.

GeoVax Labs tackles orthopoxvirus vaccine challenges, Aclarion receives AI award for back pain solution, NeuroOne's stock split, LIXTE reports cancer trial results, Stanford's urine test for bladder cancer, and more updates in medical technologies.

NRx Pharmaceuticals prepares for ketamine product approval with new CCO, Catalyst Crew Technologies aligns patents with subsidiary, and VectorCertain achieves 100% success in preventing unsanctioned AI agent scope expansion.

Lixte Biotech enhances cancer treatment with LB-100, while Annovis Bio secures funding for Phase 3 trials. Nightfood Holdings pioneers AI-enabled robotics in drug manufacturing, with Lixte Biotech and health insurers also making significant strides in the healthcare industry.

Lixte Biotech Holdings and Nightfood Holdings are pioneering precision oncology treatments and AI-enabled robotics in drug manufacturing, while Sakowitz Smiles Orthodontics revolutionizes orthodontic care with innovative technology.